Karyopharm Therapeutics (25K0.F) Q1 2025 Earnings

19FebConfirmed
Q1 2025
-3.76
-3.66
-3.56
-3.45

Details

Expected EPS
-3.7626111255
Actual EPS
-3.4542
Surprise EPS
0.31
Surprise Percent
+8.2%

Description

Karyopharm Therapeutics (25K0.F) has reported earnings of -3.4542 per share for Q1 2025.

0 Comments

Share your thoughts